Diabetic Nephropathy

ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk

Publish Date June 21, 2022

Fewer renal complications seen with tirzepatide versus insulin glargine in adults with T2D and increased cardiovascular risk

Hyperuricemia With Diabetes Compounds ESKD, Death Risks

Publish Date May 4, 2022

A study conducted in Taiwan is the first to show that hyperuricemia is as risky as diabetes in contributing to ESKD and death risk in patients with stage 3 to 5 CKD.

Combining Dapagliflozin and Eplerenone Further Reduces Albuminuria in CKD

Publish Date April 28, 2022

Study findings suggest the nephroprotective effects of both drug classes are complementary.

Underuse of Diabetic Kidney Disease Therapies Reported

Publish Date April 27, 2022

Study findings highlight an “unmet need” for newer therapies.

Uremic Solutes Tied With Cardiovascular Death in Diabetic Kidney Disease

Publish Date April 21, 2022

Investigators focused on the prognostic value of the uremic solutes asymmetric dimethylarginine, symmetric dimethylarginine, and trimethylamine-N-oxide.

Genetic Analysis Suggests BMI, Kidney Disease Link in T2DM

Publish Date March 21, 2022

Mendelian randomization study shows causal association between higher body mass index and increased risk for diabetic nephropathy

Diabetes Linked With Major Bleeding Complications After Renal Biopsy

Publish Date March 7, 2022

Diabetes is a possible risk factor for major bleeding complications after percutaneous renal biopsy, according to investigators.

Semaglutide Superior to Liraglutide for Weight Loss

Publish Date February 3, 2022

Findings reported for subcutaneous treatment in overweight, obese adults also using diet, physical activity

SGLT2 Inhibitors Underprescribed for Chronic Kidney Disease

Publish Date January 27, 2022

Affordability of SGLT2i may contribute to the low prescription rate in CKD.

Atrasentan Renoprotective Across Albuminuria, Kidney Function Subgroups

Publish Date December 8, 2021

Atrasentan lowers the risk for a composite of kidney failure, doubling of serum creatinine, or kidney death consistently across subgroups of urinary albumin-creatinine ratio and estimated glomerular filtration rate.